ASCO switches to online format for annual meeting
March 24, 2020 -- The American Society of Clinical Oncology (ASCO) will convert its 2020 annual meeting to a virtual format due to the COVID-19 outbreak.
Qiagen, NuProbe partner on next-generation sequencing liquid biopsy
March 17, 2020 -- Qiagen and molecular diagnostics company NuProbe have entered into an agreement to develop noninvasive liquid biopsy tests for cancer diagnosis using next-generation sequencing technology.
Blood test shows promise for identifying cancer
March 11, 2020 -- A blood test that tracks microbial DNA shows promise for identifying different types of cancer based on their microbiome profiles, according to a study published online March 11 in Nature. Researchers have formed a start-up company to pursue their work.  Discuss
Urine test could reduce unnecessary prostate biopsies
March 11, 2020 -- A new urine test developed by U.K. researchers shows promise for reducing unnecessary prostate biopsies, according to a study published online March 9 in the Prostate journal.  Discuss
Could liquid biopsy replace PSA for prostate cancer?
March 10, 2020 -- A liquid biopsy blood test that identifies the earliest genetic changes of prostate cancer has been developed by researchers from the U.K., who believe it could potentially replace prostate-specific antigen (PSA) testing, according to a study published online March 9 in the Journal of Clinical Investigation.  Discuss
Older women benefit from genetic breast cancer testing
March 10, 2020 -- Postmenopausal women newly diagnosed with breast cancer -- but without any hereditary risk factors -- may benefit from genetic testing for cancer-related mutations, according to a study published March 10 in JAMA.  Discuss
AACR cancels April meeting in San Diego
March 10, 2020 -- The American Association for Cancer Research (AACR) has canceled its annual meeting scheduled to take place April 24-29 in San Diego. The group cited the coronavirus outbreak as the reason for the cancellation.
TMB test predicts immunotherapy effects in lung cancer patients
March 5, 2020 -- The level of tumor mutational burden (TMB) in blood appears to be an effective biomarker for gauging response to immunotherapies and survival in patients with metastatic non-small cell lung cancer, according to a small study published February 26 in the journal Clinical Cancer Research.  Discuss
Study urges broader genetic testing of breast cancer patients
March 4, 2020 -- Women 65 and younger with a breast cancer diagnosis should be offered genetic testing to determine if they are at risk for additional cancers, according to a study published online March 3 in the Journal of Clinical Oncology.  Discuss
Biodesix expands lung cancer blood testing portfolio
March 3, 2020 -- Lung cancer diagnostics firm Biodesix has introduced Nodify CDT, a blood-based test kit designed to help identify patients with lung nodules that are at high risk of being malignant.